Print

HVTN 204

A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed By a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRC-HIVADV014-00-VP, in HIV-1 Uninfected Adult

Trial Details:

II Closed to follow-up
HVTN, National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) September 22, 2005
VRC-HIVADV014-00-VP,VRC-HIVDNA016-00-VP DNA env A, env b, env C, gag B, pol B, nef B; Ad5 env A, env B, env C, gag B, pol B
VRC-HIVDNA016-00-VP DNA
VRC-HIVADV014-00-VP Viral Vector - Adeno
South Africa, USA 480
http://www.clinicaltrials.gov/ct/show/NCT00125970?order=1